High diagnostic value of morphologic examination and molecular analysis of bone marrow biopsies in a case of BCR-ABL+ CML with clusters of blasts

International Journal of Hematology

Volumn 89, Issue 3, 2009, Pages 294-297

  Markert, Eva ^a   Siebolts, Udo ^b,c   Odenthal, Margarete ^a   Kreuzer, Karl Anton ^c   Wickenhauser, Claudia ^a,b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

B ALL; Bone marrow biopsy; CML; FISH; RT PCR

Indexed keywords

BCR ABL PROTEIN; DASATINIB; IMATINIB;

AGED; ARTICLE; B LYMPHOBLAST; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CASE REPORT; CHROMOSOME 22Q; CHROMOSOME 9Q; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; DRUG DOSE INCREASE; ESOPHAGITIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FUNGEMIA; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; BIOPSY; BONE MARROW; METABOLISM;

AGED; BIOPSY; BONE MARROW; FEMALE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;

EID: 67649195493     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0257-x     Document Type: Article

References (8)

1. CL Sawyers A Hochhaus E Feldman JM Goldman CB Miller OG Ottmann 2002 Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study Blood 99 10 3530 9
2. M Talpaz RT Silver BJ Druker JM Goldman C Gambacorti-Passerini F Guilhot 2002 Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study Blood 99 6 1928 37
3. H Kantarjian C Sawyers A Hochhaus F Guilhot C Schiffer C Gambacorti-Passerini 2002 Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia N Engl J Med 346 9 645 52
4. Ilaria RL, Jr. Pathobiology of lymphoid and myeloid blast crisis and management issues. Hematol Am Soc Hematol Educ Program 2005;188-94.
5. CW Scharenberg MA Harkey B Torok-Storb 2002 The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors Blood 99 2 507 12
6. BJ Druker F Guilhot SG O'Brien I Gathmann H Kantarjian N Gattermann 2006 Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N Engl J Med 355 23 2408 17
7. H Kantarjian S O'Brien J Cortes F Giles D Thomas S Kornblau 2003 Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications Cancer 98 1 81 5
8. TP Hughes J Kaeda S Branford Z Rudzki A Hochhaus ML Hensley 2003 Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia N Engl J Med 349 15 1423 32